IGSF8 Antikörper (Middle Region)
Kurzübersicht für IGSF8 Antikörper (Middle Region) (ABIN929376)
Target
Alle IGSF8 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Aufreinigung
- Purified
-
Immunogen
- IGSF8 antibody was raised in rabbit using the middle region of IGSF8 as the immunogen
-
-
-
-
Applikationshinweise
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
IGSF8 Blocking Peptide, (ABIN940191), is also available for use as a blocking control in assays to test for specificity of this IGSF8 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- IGSF8 (Immunoglobulin Superfamily, Member 8 (IGSF8))
-
Andere Bezeichnung
- IGSF8
-
Hintergrund
- IGSF8 may play a key role in diverse functions ascribed to CD81 and CD9 such as oocytes fertilization or hepatitis C virus function. IGSF8 may regulate proliferation and differentiation of keratinocytes. IGSF8 may be a negative regulator of cell motility: suppresses T-cell mobility coordinately with CD81, associates with CD82 to suppress prostate cancer cell migration, regulates epidermoid cell reaggregation and motility on laminin-5 with CD9 and CD81 as key linkers. IGSF8 may also play a role on integrin-dependent morphology and motility functions. IGSF8 may participate in the regulation of neurite outgrowth and maintenance of the neural network in the adult brain. Synonyms: Polyclonal IGSF8 antibody, Anti-IGSF8 antibody, immunoglobulin superfamily, member 8 antibody, CD316 antibody, CD81P3 antibody, EWI2 antibody, PGRL antibody.
Target
-